Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Trex
TREX
$4.51B
| $1.44M | ﹤0.01% |
34,111
-34,779
| -50% | -$1.58M |
|
1202
Bumble
BMBL
$372M
| $1.44M | ﹤0.01% |
68,332
-77,172
| -53% | -$1.78M |
|
1203
Evercore
EVR
$12.4B
| $1.44M | ﹤0.01% |
13,166
-15,490
| -54% | -$1.62M |
|
1204
Bunge Global
BG
$20.4B
| $1.43M | ﹤0.01% |
14,329
-129,327
| -90% | -$12.4M |
|
1205
Allegion
ALLE
$13.4B
| $1.42M | ﹤0.01% |
13,498
-13,500
| -50% | -$1.41M |
|
1206
Royal Gold
RGLD
$16.8B
| $1.42M | ﹤0.01% |
12,595
-12,595
| -50% | -$1.3M |
|
1207
Palantir
PLTR
$295B
| $1.42M | ﹤0.01% |
221,053
-221,073
| -50% | -$1.68M |
|
1208
Harley-Davidson
HOG
$2.58B
| $1.42M | ﹤0.01% |
34,045
-20,801
| -38% | -$886K |
|
1209
Celanese
CE
$4.9B
| $1.42M | ﹤0.01% |
13,844
-9,646
| -41% | -$957K |
|
1210
Acadia Healthcare
ACHC
$2.76B
| $1.41M | ﹤0.01% |
17,103
-17,105
| -50% | -$1.41M |
|
1211
Meritage Homes
MTH
$4.58B
| $1.4M | ﹤0.01% |
30,460
-31,500
| -51% | -$1.27M |
|
1212
Corsair Gaming
CRSR
$1.13B
| $1.4M | ﹤0.01% |
103,140
-109,072
| -51% | -$1.59M |
|
1213
Verde Clean Fuels
VGAS
$22.5M
| $1.4M | ﹤0.01% |
150,000
-150,000
| -50% | -$1.52M |
|
1214
Valmont Industries
VMI
$9.3B
| $1.38M | ﹤0.01% |
4,174
+268
| +7% | +$85K |
|
1215
Olin
OLN
$2.11B
| $1.38M | ﹤0.01% |
26,023
-29,283
| -53% | -$1.55M |
|
1216
Carnival Corporation Ltd
CCL
$38.1B
| $1.37M | ﹤0.01% |
170,581
-59,765
| -26% | -$515K |
|
|
DOCU
1217
DocuSign
DOCU
$10.5B
| $1.36M | ﹤0.01% |
24,486
-24,492
| -50% | -$1.19M |
|
1218
Calix
CALX
$2.26B
| $1.35M | ﹤0.01% |
19,706
-31,524
| -62% | -$2.12M |
|
1219
LeMaitre Vascular
LMAT
$2.32B
| $1.34M | ﹤0.01% |
29,146
-33,370
| -53% | -$1.56M |
|
1220
CACI
CACI
$11B
| $1.34M | ﹤0.01% |
4,456
+1
| +0% | +$292 |
|
1221
AptarGroup
ATR
$8.55B
| $1.34M | ﹤0.01% |
12,154
-12,154
| -50% | -$1.25M |
|
1222
Roadzen
RDZN
$97.2M
| $1.33M | ﹤0.01% |
130,000
-130,000
| -50% | -$1.32M |
|
|
CTAQ
1223
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
| $1.33M | ﹤0.01% |
130,258
-130,258
| -50% | -$1.31M |
|
|
SWAV
1224
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $1.33M | ﹤0.01% |
6,460
-342
| -5% | -$86.5K |
|
1225
Live Nation Entertainment
LYV
$40.5B
| $1.33M | ﹤0.01% |
19,019
-19,021
| -50% | -$1.41M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.